Actemra 400 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FWQ48
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,110
Award facts
- Contract value 100% obligated
- $7,109.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Actemra 400 mg/20 mL vials. This competitively awarded, firm fixed-price delivery order has a ceiling value of $7,109.81 and an ultimate completion date of July 30, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Actemra (tocilizumab) is a biologic immunosuppressant medication used to treat various inflammatory conditions, including rheumatoid arthritis and certain systemic inflammatory disorders.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's award demonstrates the company's capability as a major pharmaceutical distributor to fulfill federal medical procurement requirements through open competition across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FWQ48?
SPE2DB25FWQ48 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FWQ48 worth?
The government has obligated $7,110 on SPE2DB25FWQ48.
Is contract SPE2DB25FWQ48 an order under another contract?
Yes. SPE2DB25FWQ48 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FWQ48 competed?
The extent of competition for SPE2DB25FWQ48 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award